Navigation Links
Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR

ials of its product candidates, the Company's ability to develop a modified release formulation of CRx-102, potential difficulty and delays in obtaining regulatory approval for the sale and marketing of its product candidates, the Company's ability to obtain additional financing or funding for its research and development and those other risks that can be found in the "Risk Factors" section of the CombinatoRx Annual Report on Form 10-K on file with the Securities and Exchange Commission and the other reports that CombinatoRx periodically files with the Securities and Exchange Commission. Actual results may differ materially from those CombinatoRx contemplated by these forward-looking statements. CombinatoRx does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this release.

(c) 2007 CombinatoRx, Incorporated. All rights reserved.

Contact

CombinatoRx, Incorporated
Robert Forrester, 617-301-7100
EVP, Chief Financial Officer
rforrester@combinatorx.com
or
Gina Nugent, 617-301-7099
VP, Corporate Communications and IR
gnugent@combinatorx.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
4. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
5. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
6. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
7. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
11. PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
Post Your Comments:
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... Nov. 26, 2014  Aridis Pharmaceuticals, Inc., a ... therapies for infectious diseases, announced today the addition ... recognized key opinion leader in the areas of ... board. Founder and Chief Executive Officer, ... Dr. Opal,s extensive experience investigating bacterial toxins and ...
(Date:11/26/2014)... and NEW YORK ... As the leading distributor of market intelligence, ... new research report by IQ4I Research and Consultancy focusing ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast to ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Beginning today, Northside Hospital and Atlanta Perinatal Consultants announce ... test for common fetal trisomies, such as trisomy 21 ... Edwards syndrome. The Harmony Prenatal Test, ... testing platform to analyze DNA in maternal blood so ...
... 26, 2012 Quest International, Inc., a leading global ... solutions, announced today that is has contributed $5000 to ... the American Cancer Society Key Gala, that benefits the ... Massachusetts on Thursday, March 29, 2012. "We ...
Cached Medicine Technology:Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 2Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 3Quest International Donates $5000 to the American Cancer Society 2
(Date:11/28/2014)... Miami, FL (PRWEB) November 28, 2014 ... contemporary, responsive website. Practice founder Dr. Jeffrey ... site. Created using a groundbreaking WordPress platform, the ... devices. , Currently, up to 75% of ... More than ever, these people are logging on with ...
(Date:11/28/2014)... (HealthDay News) -- Celebration can quickly turn to ... Day, experts say. Over the last decade, more ... while people were using turkey fryers, according to the ... cared for a patient who tried to deep fry ... in any circumstances," Dr. Arthur Sanford, a burn surgeon ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, Wash., was using ... was almost impossible to reach. "This gave me the idea ... patent-pending Access Light allows for easier use of a dental ... as well as avoids harm to the lips, tongue and ... clean, it also helps prevent cross-contamination. , The original design ...
(Date:11/28/2014)... 28, 2014 UniWigs.com, a leader in the wig ... Friday to the next Monday. This promotion features: , ... 40 items up to 70% off (no coupon code needed), ... > Free shipping on orders over $49 , Visit http://www.uniwigs.com ... days from Nov. 28th to Dec. 1st and the first 100 ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic and ... to its students. That is why the Virginia ... structure at its mental health services facility in ... for children who are identified as needing additional ... served the needs of children with severe emotional ...
Breaking Medicine News(10 mins):Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:Pre-X'mas Crazy Sale Starts from $0 at UniWigs.com 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3
... a national single-payer style healthcare reform system would provide ... 2.6 million new jobs, and infusing $317 billion in ... in wages into the U.S. economy, according to the ... be viewed at www.CalNurses.org . The number ...
... The pharmaceutical industry is currently facing some ... costs, a decrease in the number of ... authorities are forcing companies to look at ... also demanding more effective and safer drugs.(Logo: ...
... Dental Studio (ORA) opened its second location at a renovated space in ... ... Dental Studio (ORA) opened its second location at a renovated space ... will introduce a fresh, progressive approach to general, aesthetic, and oral surgery ...
... presents an audio-slide presentation on the Diabetes Best Practices Website, analyzing ... control in treating type 2 diabetes as well as preventing heart ... ... -- Effectively and safely achieving glycemic goal has long been considered ...
... Peanut Corporation of America (PCA), a peanut processing ... to institutions, food service industries, and private label food ... produced in its Blakely, Georgia processing facility because it ... All product affected was produced on or after July ...
... Former Commissioner of the Food and Drug Administration Finds ... 13 On April 27, 2009 Rodale will publish "The ... by Dr. David A. Kessler who served as commissioner of ... and Bill Clinton. Over the course of seven ...
Cached Medicine News:Health News:First-of-Its Kind Study: Medicare for All (Single-Payer) Reform Would Be Major Stimulus for Economy With 2.6 Million New Jobs, $317 Billion in Business Revenue, $100 Billion in Wages 2Health News:First-of-Its Kind Study: Medicare for All (Single-Payer) Reform Would Be Major Stimulus for Economy With 2.6 Million New Jobs, $317 Billion in Business Revenue, $100 Billion in Wages 3Health News:First-of-Its Kind Study: Medicare for All (Single-Payer) Reform Would Be Major Stimulus for Economy With 2.6 Million New Jobs, $317 Billion in Business Revenue, $100 Billion in Wages 4Health News:Personalised Medicine: An Opportunity for Investment 2Health News:Personalised Medicine: An Opportunity for Investment 3Health News:Chicago's First Eco-friendly, Green Luxury Dental Practice - ORA Dental Studio - is Finally Here 2Health News:Diabetes and Cardiovascular Disease: Online Presentation Looks at the Complex Relationship of These Two Diseases in Light of Recent Studies 2Health News:Peanut Corporation of America Announces Voluntary Nationwide Recall of Peanut Butter 2Health News:Peanut Corporation of America Announces Voluntary Nationwide Recall of Peanut Butter 3Health News:Rodale to Publish Dr. David A. Kessler 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: